13-41068620-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007187.5(WBP4):āc.322A>Gā(p.Asn108Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,613,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_007187.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WBP4 | NM_007187.5 | c.322A>G | p.Asn108Asp | missense_variant | 5/10 | ENST00000379487.5 | NP_009118.1 | |
WBP4 | XM_005266245.3 | c.415A>G | p.Asn139Asp | missense_variant | 5/10 | XP_005266302.1 | ||
WBP4 | XM_047430071.1 | c.-100A>G | upstream_gene_variant | XP_047286027.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000885 AC: 22AN: 248524Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 134614
GnomAD4 exome AF: 0.0000630 AC: 92AN: 1461436Hom.: 0 Cov.: 30 AF XY: 0.0000770 AC XY: 56AN XY: 727028
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 22, 2024 | The c.322A>G (p.N108D) alteration is located in exon 5 (coding exon 5) of the WBP4 gene. This alteration results from a A to G substitution at nucleotide position 322, causing the asparagine (N) at amino acid position 108 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at